Guinea pig eotaxin is a recently described member of the Cys-Cys family of chemokines and is involved in a guinea pig model of asthma. To determine whether eotaxin is a distinctive member of this family and to understand its physiologic role, we have cloned the mouse eotaxin gene and determined its structure and aspects of its biologic function. The sequence relationship between the mouse and guinea pig genes indicates that eotaxin is indeed a distinct member of the chemokine family. Moreover, murine eotaxin maps to a region of mouse chromosome 11 that encodes other Cys-Cys chemokines. In addition, recombinant murine eotaxin protein has direct chemoattractant properties for eosinophils. The eotaxin gene is widely (but not ubiquitously) expressed in normal mice and is strongly induced in cultured endothelial cells in response to interferon y. Eotaxin is also induced locally in response to the transplantation of interleukin 4-secreting tumor cells, indicating that it likely contributes to the eosinophil recruitment and antitumor effect of interleukin 4. Such responses suggest that eotaxin may be involved in multiple inflammatory states.
The chemokines are a family of 8-to 12-kDa proteins that regulate leukocyte trafficking by binding to specific seventransmembrane-spanning G-protein-linked receptors (1) . They can be divided into three families depending on the sequence of conserved Cys residues and this structural distinction corresponds to specific biologic properties in that the Cys-Xaa-Cys (or a), Cys-Cys (or 13) and Cys families are mainly chemoattractive for neutrophils, monocytes, and lymphocytes, respectively.
Eosinophils are circulating leukocytes that are thought to dwell predominantly in tissues where they survive for several weeks and mediate proinflammatory and cytototoxic damage in selected diseases (2) . The regulation of tissue recruitment of eosinophils is an active area of investigation and various chemokines have been found to be active on eosinophils (3) . Chemokines active on eosinophils include certain Cys-Cys chemokines: monocyte chemoattractive protein (MCP)-2, MCP-3, RANTES, and macrophage inflammatory protein (MIP)-1c, (1, 4) . A Cys-Xaa-Cys chemokine, interleukin (IL) 8, is also chemoattractive for cytokine-primed eosinophils (1) . None of these chemoattractive molecules are eosinophilspecific and their relative importance in selected diseases and in experimental animal models of allergy remains unclear.
In contrast to the above noted agents, eotaxin, a recently described Cys-Cys chemokine, has been implicated as an eosinophil chemoattractant in a guinea pig (gp) model of allergic airway inflammation (5, 6 ). Eotaxin appears to be unique among the chemokines since it causes the selective infiltration of only eosinophils when injected into the skin and when directly administered to the lungs of naive gps. It has been unclear whether gp eotaxin represents a homologue of a previously known chemokine or is a distinct chemokine. Furthermore, the biological significance of eotaxin in models of nonallergic disease has not been examined. By using the gp eotaxin cDNA as a molecular probe (7, 8) , we now identify murine eotaxin § and examine its biological properties.
MATERIALS AND METHODS
Eotaxin Genetic Analysis. A cDNA probe from the coding region of gp eotaxin cDNA (bp 57-356) (8) was used to screen a murine 129SV genomic library (Stratagene) under conditions of low stringency (8) . Restriction mapping of two hybridizing genomic clones indicated overlapping regions. A 1.4-kb EcoRV genomic fragment was used to screen a murine (C57BL/6 x CBA) lung Uni-Zap cDNA expression library (Stratagene) under conditions of high stringency. Four inserts were sequenced on both strands by automated sequencing and analyzed (9, 10) .
Eotaxin chromosomal localization was determined by the analysis of polymorphism in the CA repeat found in intron 2. PCR primers flanking this repeat were constructed (5' sense oligonucleotide, CACCCTGAAAGCCATAGTGT; 3' antisense oligonucleotide, TGTGTACCTGGGAAATTAG) and genomic DNA was amplified by PCR from a panel of DNA from 94 interspecific backcrosses between (C57BL/6EiJ x SPRET/Ei)F1 x SPRET/Ei (BSS) (11) .
RNA Analysis. RNA was isolated (8) from a simian virus 40-immortalized murine endothelial cell line (12) cultured with or without recombinant murine interferon y (IFN--y; Genentech) at 200 units/ml, mouse bone marrow-derived mast cells (13) , WEHI-3, P815, and RAW 264.7 (American Type Culture Collection). In the tumor transplantation experiments, 2 x 106 J558L or a murine IL-4-transfected J558L cell line (I3L6) were injected s.c. into 4-to 6-week-old BALB/c female mice as described (14) prior to extraction of RNA from local skin. Total RNA (10 ,ug) was fractionated by gel electrophoresis and transferred 'to GeneScreen (DuPont/NEN) membranes. The murine MCP-1 probe was a kind gift from B. J. Rollins (15) . The quantification of total RNA was determined by hybridization of a 28S rRNA cDNA probe (16) and by using a Phosphorlmager (Molecular Dynamics).
Construction and Transfection of Eotaxin Expression Vectors. The coding region of murine eotaxin was PCR-amplified, subcloned, subjected to confirmatory sequencing, subcloned into the HindIII-EcoRI sites of pcDNA-I/Amp (Invitrogen), and transfected into COS cells by DEAE-dextran. RNA expression was confirmed by Northern blot analysis using the murine eotaxin cDNA as a probe. COS cell supernatant was Abbreviations: gp, guinea pig; IL, interleukin; IEN, interferon; MCP, macrophage chemoattractant protein; MIP, macrophage inflammatory protein; PAF, platelet activating factor. tTo whom reprint requests should be addressed. §The sequence reported in this paper has been deposited in the GenBank data base (accession no. U26426); the chromosomal mapping has been deposited in the Mouse Genome Data Base (accession no. MGD-CREX-329).
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collected after 72 h. Eotaxin cDNA was also subcloned into the HindIII-EcoRI site of MoLTR-SV40 I/PA expression vector (17 (18) . Eosinophils were purified from the spleen by using immunomagnetic separation to remove the contaminating splenocytes (M.E.R., unpublished results). Briefly, splenocytes were labeled with anti-Thy-1 (M5/49), anti-B220 (6B2), and antiLyt-2 (53-6.7) and treated with sheep anti-rat serum-coated magnetic beads (M450, Dynal), and eosinophils were enriched by negative selection through a magnetic field. The resulting preparations were 85-92% eosinophils. Macrophages and neutrophils were isolated from the peritoneal cavity of mice that had been pretreated with intraperitoneal injection of 2.9%
(wt/vol) thioglycollate (Difco) or sodium casein, respectively (19) . After Percoll gradients (19) , macrophages and neutrophils were >90% pure. Eosinophils, macrophages, and neutrophils were suspended in Hanks' saline with 0.05% bovine serum albumin at 2, 5, and 2.5 x 106 cells per ml, respectively, and replicate cells were placed in the top well of a 48-well microchemotaxis chamber (Neuroprobe, Cabin John, MD). A polycarbonate filter with 5-,um pores (eosinophils and macrophages) and a polyvinylpyrrolidone-free filter with 3-,um pores (neutrophils) separated the cells from buffer alone or buffer containing recombinant murine MIP-1a (R & D Systems), platelet activating factor (PAF) (Calbiochem), COS-cell supernatant, or J558L supernatant. Cells were incubated at 37°C for 60 min (eosinophils and neutrophils) or 90 min (macrophages), and the cells that migrated across the filter and adhered to the bottom side of the filter were stained with Diff-Quick (Baxter Scientific Products, McGaw Park, IL). The number of cells per 400X field was counted. stringency conditions were used to screen a murine genomic library. Two overlapping clones were recovered and, from these, a 1.4-kb EcoRV genomic fragment was identified that hybridized to gp eotaxin cDNA. Sequence analysis revealed that it encoded two exons with striking homology to gp eotaxin ( Fig. 1 ). Exon 1 mapped to the 5-kb EcoRI-Xho I fragment ( Fig. 1 ).
The sequence of the cloned genomic fragment revealed a stretch of 18 CA repeats in the intron between exons 2 and 3 that facilitated the chromosomal mapping of this gene. PCR primers flanking the repeat were used to amplify genomic DNA from several strains of mice and revealed a PCR product of similar size in the 129SV, DBA/2J, and C57BL/6J genomes.
In contrast, DNA from Mus spretus amplified a larger PCR product, indicating a dinucleotide polymorphism ( Fig. 2A) untranslated region contained three "AUUUA" domains. Sequences of this type have been reported to decrease the mRNA stability of other cytokine mRNAs and are also present in gp eotaxin (8) .
Examination of the nucleotide and protein sequences revealed that murine eotaxin was different than other sequenced murine chemokines and most homologous to gp eotaxin (Table 1) . Gp and murine eotaxin are most homologous to members of the MCP family. Nonetheless, several features distinguish eotaxin from the MCP proteins (Fig. 3) . The predicted mature eotaxin proteins start with His-Pro, whereas MCP family members start with Gln-Pro. Further, the third amino acid in mature gp and murine eotaxin is Gly, which distinguishes it from the MCPs. Gp and murine eotaxin also have a gap at aa 6 and 7 in their mature proteins that distinguishes them from the other Cys-Cys chemokines. Moreover, due to the C-terminal end of eotaxin that is rich in basic amino acids (including the conservation of three consecutive Lys residues), the predicted pI and charge at pH 7 are 10 and 12, respectively.
Eosinophil Chemotaxis by Eotaxin. The chemoattractant activity of the murine eotaxin protein was examined by expressing murine eotaxin cDNA in two eukaryotic expression systems and testing their products on murine eosinophils in vitro. (i) Stable transfectants of plasmacytoma cells (J558L) with a murine leukemia virus MoLTR-eotaxin construct were derived and grown in serum-free medium. (ii) The eotaxin cDNA was subcloned into the pcDNA-I/Amp plasmid and used for transient transfection of COS cells. The supernatants of these cells provided a source of eotaxin protein.
Normal mice do not have appreciable numbers of eosinophils so murine eosinophils were purified from IL-5 transgenic mice. IL-5 is an eosinophil growth and activating factor and IL-5 transgenic mice have profound eosinophilia that facilitated their isolation (18) . Murine eosinophils exhibited a strong chemotactic response to 10-6 to 10-7 M PAF and recombinant murine MIP-1a at 100-1000 ng/ml both positive controls (Fig. 4A) . The eotaxin J558L supernatant also demonstrated a strong eosinophil chemotactic activity compared to the negative control supernatant. The possible inhibitory effect of the control supernatant may relate to the release of toxic metabolites during the harvesting of the cell supernatant. The supernatant from transfected COS cells also produced an increase in chemotaxis compared to mock-transfected COScell supernatant (Fig. 4B) . In all experiments, migrating cells were >95% eosinophils. Eotaxin-COS cell and J558L cell supernatants had no activity on murine macrophages or neu- trophils, whereas the macrophages had a strong chemotactic response to murine MIP-la and the neutrophils had a strong chemotactic response to KC, the murine homologue of IL-8 (data not shown).
Analysis of Eotaxin mRNA Expression in Mice. Analysis of an equal amount of total RNA by optical density and ethidium bromide staining revealed easily detectable levels of eotaxin mRNA expression in skin, thymus, lymph node, mammary gland, and skeletal muscle and lower levels in the heart and lung (Fig. 5 ). Other tissue with expression included the stomach, tongue, and one spleen sample (data not shown). As predicted from the size of the cDNA, the mRNA transcript was -1 kb.
Regulation of Eotaxin mRNA Expression in Vivo by IL-4. When IL-4-transfected tumor cells are transplanted into the skin of syngeneic or immunodeficient mice, there is a remarkable eosinophil infiltration within 18 hr (14) . These eosinophils have been shown to be critical for the antitumor effect of IL-4 (20) , although the mechanism of their recruitment is not understood. Eotaxin would be a logical candidate for this role. To assess this possibility, eotaxin mRNA expression at the site of tumor-cell transplantation was assayed after transplantation of the IL-4-producing tumor cells. Within 6 hr, there was a marked increase in eotaxin mRNA compared with controls (transplanted untransfected tumor cells or untreated skin) (Fig. 6A) . This increase persisted for 7 days. Fig. 6B shows representative data at 24 hr for untransplanted mice and mice transplanted with IL-4-producing and nonproducing tumor cells.
Production of Eotaxin by Endothelial Cells. Since endothelial cells are known to produce several chemokines including MCP-1 (21) that are increased by IFN-,y, the ability of IFN-,y to induce eotaxin mRNA expression in endothelial cells was also examined. A simian virus 40-immortalized murine endothelial cell line was treated with cytokine, and total RNA was analyzed by RNA blot hybridization. Eotaxin mRNA was undetectable in nontreated cells but was detectable by 6 hr of treatment with IFN-,y (Fig. 6C ) and returned to an undetectable level by 18 hr. As a control, murine MCP-1 mRNA was found to be readily detectable constitutively and to be increased by IFN-,y treatment (Fig. 6C) as reported (21) .
Eotaxin mRNA expression in mast cells and macrophages was also examined. Whereas the macrophage cell line, RAW 264.7, had easily detectable levels of murine MCP-1 mRNA that increased after 18 hr of IFN--y, untreated and treated cells had no eotaxin mRNA detectable (data not shown). Similarly, Northern blot analysis of total RNA from mouse organs from FVB/N (lanes 1-9) and C57BL/6 mouse strains (lanes 10-17) .
High-stringency hybridization with a full-length eotaxin cDNA probe was performed and x-ray film was exposed for 1 day. 
DISCUSSION
The structural similarities between mouse and gp eotaxin indicate that both are more closely related to one another than to other members of the Cys-Cys family of chemokines. For example, each contains several unique features including a gap of 2 aa near the N-terminal end of the protein and the conservation of basic amino acids near the C-terminal end that distinguish it from other Cys-Cys chemokines. It is also noteworthy that the N-terminal end of MCP-1, including the N-terminal Gln, which has been shown to be critical for monocyte activity (22) , is replaced by a His in both murine and gp eotaxin. These comparisons indicate that eotaxin is a distinct cytokine and not a homologue of a known member of this family. In addition, we have determined that eotaxin resides on mouse chromosome 11 in a region encoding other members of the Cys-Cys chemokine family.
To demonstrate direct eosinophil chemotactic activity, we isolated eosinophils from IL-5 transgenic mice and measured eosinophil chemotaxis in vitro. It is important to note that, despite the fact that there are large numbers of eosinophils in the hematopoietic organs of these IL-5 transgenic mice, there are few eosinophils in other tissues and these transgenic mice are quite healthy (18) . This benign phenotype suggests that other signals (in addition to IL-5) are necessary for eosinophil tissue recruitment and activation. By using eosinophils from this system, we showed that recombinant murine eotaxin is a powerful chemoattractant for eosinophils as are murine MIP-la and PAF, which were used as positive controls. No chemoattractive activity was seen for eotaxin on macrophages or neutrophils. Neither MIP-l1 nor PAF is active solely on eosinophils, making it difficult to use them to develop clinically useful antagonists against eosinophils (1, 3) . However, the biological properties attributed to eotaxin in gp and mice make it likely that there will be a similar activity and thus pharmacological utility, in humans. It is likely that the eosinophils isolated from the IL-5 transgenic mice have been primed in vivo by IL-5 exposure and this potentiates their responsiveness to eotaxin. Consistent with this, IL-5 activates eosinophils and primes them to respond to RANTES in vitro (23, 24) .
As would be expected, eotaxin mRNA is constitutively expressed in mucosal tissues wherein eosinophils normally reside (skin, lung, and intestinal tract). Nonetheless, expression is also seen in thymus, lymph node, and muscle where resident eosinophils are rare. This pattern of mRNA tissue distribution is similar to that seen in gp, although mice have higher expression in the thymus and skin and gps have higher expression in the lung (8) . This is consistent with the fact that gps have high basal numbers of eosinophils in the lungs, while pulmonary eosinophils are undetectable in healthy mice. Such observations are further consistent with a role for eotaxin in promoting eosinophil pulmonary homing. The expression of eotaxin in the skin has implications for cutaneous disease in humans since there are many disorders characterized by excessive infiltration and activation of skin eosinophils. The unexpected, but appreciable, expression of eotaxin mRNA in lymphoid tissue and muscle suggests that eotaxin may affect other cell types because eosinophils do not normally reside in these tissues. The expression in the thymus and lymph node suggests that eotaxin may direct lymphocyte homing. The expression we observe in the thymus may be related to the constitutive expression of other chemokines in thymic epithelium (25) . Preliminary experiments have shown eotaxin mRNA is enriched in thymic epithelium (data not shown).
Our studies also offer a potential explanation for the observation that eosinophils infiltrate a variety of human tumors, an observation that is generally associated with an improved prognosis for such patients (26) . As noted above, the elaboration of IL-4 by a tumor transplant induces a potent antitumor effect that is mediated by infiltrating eosinophils (14, 20) . Above we have also shown that eotaxin mRNA is induced at the site of the IL-4-transfected tumor cell transplant. Thus, eotaxin may be the critical eosinophil chemoattractant that, in part, mediates eosinophil tissue recruitment in this process. It is further conceivable that eotaxin is involved in other disease states mediated by IL-4 (e.g., asthma).
As we have noted, the mechanism of IL-4-mediated eosinophil accumulation in the tumor model and in allergic models is not completely understood. It is likely that IL-4 works in conjunction with other accessory cells to induce eosinophil recruitment. Consistent with this, IL-4 is known to induce the expression of the eosinophil endothelial cell adhesion receptor [vascular cell adhesion molecule 1 (VCAM-1)] and to promote the production of Th2 cells, which elaborate IL-5. However, treatment of mice with neutralizing antibodies against VCAM-1 or IL-5 does not completely block eosinophil infiltration into tumor cells (20, 27) . In contrast, IFN-,y production is increased in this process and treatment of mice with antibodies that neutralize IFN-,y does prevent tumor killing (28) . The cellular source of eotaxin mRNA found after IL-4 tumor cell transplantation is not known, but we have seen that treatment of endothelial cells with IFN-y induces expression of eotaxin mRNA. The identification of endothelial cells and not mast cells as a cellular source of eotaxin has important implications for the design of therapeutic agents that would inhibit the production of eotaxin. However, mast cells exist as heterogeneous populations and it will be interesting to determine whether other mast cell populations produce eotaxin.
